Spontaneous and mitomycin-C-induced micronuclei in human lymphocytes exposed to extremely low frequency pulsed magnetic fields. 1991

M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
Istituto di Ricerca per l'Elettromagnetismo e i Componenti Elettronici Consiglio Nazionale delle Ricerche, Napoli, Italy.

The cytokinesis block micronucleus method, a very sensitive cytogenetic assay, was used to ascertain the possible genotoxic effects of extremely low frequency pulsed magnetic fields in phytohemagglutinin-stimulated human lymphocytes cultures from 16 healthy donors. Four conditions were studied: i) lymphocytes not exposed to the field (control cultures); ii) lymphocytes exposed to the field; iii) lymphocytes treated with mitomycin-C and not exposed to the field; iv) lymphocytes treated with mitomycin-C and exposed to the field. Mitomycin-C-treated cultures were used as control for the micronucleus method, because it is known that mitomycin-C is a potent genotoxic agent, capable of inducing micronuclei. The frequency of micronuclei in field-exposed cultures was similar to the spontaneous frequency observed in control unexposed-cultures. Moreover, the exposure to pulsed magnetic fields did not affect the frequency of micronuclei induced by mitomycin-C, suggesting that, in the experimental conditions used, this kind of field neither affected the integrity of chromosomes nor interfered with the genotoxic activity of mitomycin-C.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008280 Magnetics The study of MAGNETIC PHENOMENA. Magnetic
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980
D048629 Micronuclei, Chromosome-Defective Defective nuclei produced during the TELOPHASE of MITOSIS or MEIOSIS by lagging CHROMOSOMES or chromosome fragments derived from spontaneous or experimentally induced chromosomal structural changes. Chromosome-Defective Micronuclei,Genotoxicant-Induced Micronuclei,Micronuclei, Genotoxicant-Induced,Micronucleus, Chromosome-Defective,Chromosome Defective Micronuclei,Chromosome-Defective Micronucleus,Genotoxicant Induced Micronuclei,Genotoxicant-Induced Micronucleus,Micronuclei, Chromosome Defective,Micronuclei, Genotoxicant Induced,Micronucleus, Chromosome Defective,Micronucleus, Genotoxicant-Induced

Related Publications

M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
December 2012, Mutation research,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
June 2016, Physics in medicine and biology,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
January 1997, Life sciences,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
January 2013, Biochemical and biophysical research communications,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
July 2016, Bioelectromagnetics,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
March 2005, Free radical research,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
October 1996, Mutation research,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
April 1989, Radiation research,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
June 1992, Radiation research,
M R Scarfi, and F Bersani, and A Cossarizza, and D Monti, and G Castellani, and R Cadossi, and G Franceschetti, and C Franceschi
October 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
Copied contents to your clipboard!